Antiprogestin Drugs: Ethical, Legal and Medical Issues
Cook, Rebecca J.
Grimes, David A.
Law, Medicine and Health Care. 1992 Fall; 20(3): 149-153.
The antiprogestin drug mifepristone, popularly known as RU 486, provides women with the choice of abortion by nonsurgical means. Nonsurgical abortion is coming to be described as medical abortion, in contrast to surgical abortion. For the overwhelming majority of women for whom the drug is suitable and available, the choice it offers is between surgical and non-surgical abortion, and not between having and not having an abortion. The drug is therefore relevant to the issue of abortion technique rather than to the legality, morality or ethics of abortion itself. It would be naive, however, to claim that availability of RU 486 as an abortifacient can be separated from the whirlwind of issues surrounding abortion. Acrimonious debate concerning induced abortion often appears to present a seamless web of issues, each connected to other issues to reinforce arguments that advance individual agendas. Nevertheless, it is possible to isolate a particular area for examination and debate. In this spirit, the American Society of Law and Medicine held its conference in December, 1991, entitled
Abortion; Accountability; Adolescents; Attitudes; Autonomy; Behavioral Research; Cancer; Conscience; Contraception; Drug Industry; Drugs; Ethical Analysis; Ethics; Health; Industry; International Aspects; Induced Abortion; Law; Legal Aspects; Legal Liability; Liability; Medicine; Methods; Morality; Patient Care; Pharmacists; Physicians; Politics; Pregnant Women; Privacy; Public Policy; Regulation; Research; Risks and Benefits; Women's Health;
Showing items related by title, author, creator and subject.